AgenticSum: An Agentic Inference-Time Framework for Faithful Clinical Text Summarization
Organizations: University of Delaware, Newark, DE, USA
Abstract
Large language models (LLMs) offer substantial promise for automating clinical text summarization, yet maintaining factual consistency remains challenging due to the length, noise, and heterogeneity of clinical documentation. We present AgenticSum, an inference-time, agentic framework that separates context selection, generation, verification, and targeted correction to reduce hallucinated content. The framework decomposes summarization into coordinated stages that compress task-relevant context, generate an initial draft, identify weakly supported spans using internal attention grounding signals, and selectively revise flagged content under supervisory control. We evaluate AgenticSum on two public datasets, using reference-based metrics, LLM-as-a-judge assessment, and human evaluation. Across various measures, AgenticSum demonstrates consistent improvements compared to vanilla LLMs and other strong baselines. Our results indicate that structured, agentic design with targeted correction offers an effective inference time solution to improve clinical note summarization using LLMs.
Figures & tables
| Model | MIMIC-IV | SOAP Summary | ||||||
| ROUGE-L | BLEU-1 | BLEU-2 | BERTScore | ROUGE-L | BLEU-1 | BLEU-2 | BERTScore | |
| ( ) | ( ) | ( ) | ( ) | ( ) | ( ) | ( ) | ( ) | |
| BioBART | ||||||||
| T5-Large | ||||||||
| Flan-T5 | ||||||||
| Gemma3-1B | ||||||||
| Model | MIMIC-IV | SOAP Summary | ||||||
| Hallucination | Completeness | Coherence | Factual | Hallucination | Completeness | Coherence | Factual | |
| ( ) | ( ) | ( ) | ( ) | ( ) | ( ) | ( ) | ( ) | |
| BioBART | ||||||||
| T5-Large | ||||||||
| Flan-T5 | ||||||||
| Gemma3-1B | ||||||||
| Clinical Domain | Correct Guess | Mean Hallucination Severity | Effect Size | Dominance |
| Accuracy (%) | Vanilla / AgenticSum | ( ) | ||
| Psychiatric | 91.3 | 3.74 / 1.91 | 0.905 | |
| Cardiopulmonary | 78.3 | 3.91 / 2.09 | 0.800 | 0.005 |
| Oncology | 87.0 | 4.13 / 1.96 | 0.909 |
Appendix figures & tables4 assets
Supplementary material from the paper’s appendix.
Appendix
| Model | MIMIC-IV | SOAP Summary | ||||||
| BLEU-1 | BLEU-2 | BERT F1 | ROUGE-L | BLEU-1 | BLEU-2 | BERT F1 | ROUGE-L | |
| ( ) | ( ) | ( ) | ( ) | ( ) | ( ) | ( ) | ( ) | |
| Vanilla LLM | ||||||||
| DraftAgent (FOCUS+LLM) | ||||||||
| FixAgent (W/out Supervisor) | ||||||||
| AgenticSum (Final, w/ Clinical Supervisor) | ||||||||
| Source Document (Excerpt) |
| Patient was in good health until 10 days ago, when he began experiencing gradually worsening headaches. Head CT revealed an intracranial mass lesion. An enhancing focus in the left parapharyngeal region likely represents an abnormally enlarged lymph node, though it is not fully visualized. The imaging raises the possibility of a benign neoplasm (question neurogenic tumor), and pathology is pending. Discharge medications include atenolol, phenytoin, docusate sodium, and dexamethasone. |
| Generated Summary |
| The patient is a 10-year-old male who was experiencing worsening headaches. A CT scan revealed an intracranial mass lesion, which was found to be an abnormally enlarged lymph node representing metastatic involvement . The pathology pending at the time of discharge is a benign neurogenic tumor . The patient was prescribed atenolol, phenytoin, docusate sodium, and dexamethasone. |
| Hallucination Detector agent Analysis |
| Factuality Verdict: UNSUPPORTED |
| Explanation: The patient’s age and gender are unspecified. The lymph node is described as potentially benign, not definitively metastatic. Pathology is still pending at discharge. The hallucinated spans introduce unwarranted specificity and certainty. |
| Source Document (Clinical Note) |
| <SEX> F |
| <SERVICE> SURGERY |
| <ALLERGIES> Iodine / contrast dye allergy. |
| The patient reports persistent abdominal pain that has worsened over the past week. |
| She states that despite taking her medications, the pain has not resolved. |
| She denies fever, chills, cough, or shortness of breath. |
| Source Document (Clinical Note) |
| Male patient with major depressive disorder presents with chronic, intractable nausea that began in childhood and is associated with his depression. Last night, he experienced the worst nausea of his life, leading to suicidal ideation with a plan for carbon monoxide poisoning. He is currently undergoing ECT treatment (2 sessions completed). The patient reports anxiety exacerbates his nausea, and he describes himself as a ”worrier.” He no longer has active suicidal thoughts but worries about future episodes. Physical exam shows psychomotor retardation, depressed affect, slow speech with pauses, and fine tremor. Lab results are within normal limits. He is alert, oriented, and ambulatory. Current medications include: omeprazole, ranitidine, phenelzine, clonazepam, tamsulosin, and aripiprazole. |
| DraftAgent Summary (Initial) |
| The patient is a male who has been experiencing intractable nausea associated with depressive symptoms. He has a history of car accidents and has been prescribed ECT treatments. The patient reports that he is upset about his inability to throw up and is experiencing anxiety. He has a history of depression and anxiety, and has been taking medication for both conditions. The patient’s plan is to try the first round of ECT, and he is being treated by Dr. Stern . The patient’s physical examination reveals normal findings . The patient’s speech is slow and with many pauses, and his behavior is cooperative with psychomotor retardation. The patient’s thought process is linear and goal-directed. The patient is currently taking several medications, including omeprazole, ranitidine, phenelzine, clonazepam, tamsulosin, and aripiprazole. The patient is alert and interactive, and is ambulatory and independent. |
| FixAgent Summary (Corrected) |
| The patient is a male with major depressive disorder and persistent nausea. He has undergone two ECT sessions. The patient reports distress due to the intractable nausea, which is worsened by anxiety. He is undergoing ECT under medical supervision. The physical exam shows psychomotor retardation, slow speech, and cooperative behavior. The patient’s thought process is linear and goal-directed. He is currently taking omeprazole, ranitidine, phenelzine, clonazepam, tamsulosin, and aripiprazole. He is alert, interactive, and ambulatory. |
| FixAgent Analysis |